C Friedenreich1, H Bryant, F Alexander, J Hugh, J Danyluk, D Page. 1. Division of Epidemiology, Prevention and Screening, Alberta Cancer Board, 1331-29 St NW, Calgary, Alberta, Canada, T2N 4N2. chrisf@acb-epi.ucalgary.ca
Abstract
BACKGROUND: As part of a nested case-control study of benign proliferative breast disease (BPBD) conducted within the cohort of women participating in the Alberta breast screening programme, an analysis of all women who had a benign breast biopsy between 1990 and 1995 was undertaken to identify the epidemiological risk factors for BPBD. METHODS: The breast biopsies of all eligible women were re-reviewed by a panel of four pathologists using Page's classification for benign breast disease. Cases were 165 women whose biopsies, upon review, showed benign breast tissue changes ranging from sclerosing adenosis to atypical ductal hyperplasia. Controls were 217 women whose biopsies showed no evidence of any proliferative or neoplastic changes. In-person interviews were conducted with all study subjects. RESULTS: Women with >/=25% fibroglandular breast tissue density, as compared to women with <25% density, experienced nearly a doubling in risk of BPBD (OR = 1.91, 95% CI : 1.24-2.94). All other possible risk factors examined were not associated with BPBD. CONCLUSION: This study suggests that fibroglandular tissue density may be a risk factor, or marker, for increased risk of BPBD.
BACKGROUND: As part of a nested case-control study of benign proliferative breast disease (BPBD) conducted within the cohort of women participating in the Alberta breast screening programme, an analysis of all women who had a benign breast biopsy between 1990 and 1995 was undertaken to identify the epidemiological risk factors for BPBD. METHODS: The breast biopsies of all eligible women were re-reviewed by a panel of four pathologists using Page's classification for benign breast disease. Cases were 165 women whose biopsies, upon review, showed benign breast tissue changes ranging from sclerosing adenosis to atypical ductal hyperplasia. Controls were 217 women whose biopsies showed no evidence of any proliferative or neoplastic changes. In-person interviews were conducted with all study subjects. RESULTS:Women with >/=25% fibroglandular breast tissue density, as compared to women with <25% density, experienced nearly a doubling in risk of BPBD (OR = 1.91, 95% CI : 1.24-2.94). All other possible risk factors examined were not associated with BPBD. CONCLUSION: This study suggests that fibroglandular tissue density may be a risk factor, or marker, for increased risk of BPBD.
Authors: Ying Liu; Rulla M Tamimi; Catherine S Berkey; Walter C Willett; Laura C Collins; Stuart J Schnitt; James L Connolly; Graham A Colditz Journal: Pediatrics Date: 2012-04-09 Impact factor: 7.124
Authors: Vassilios J Papantoniou; Evangelia K Sotiropoulou; Pipitsa N Valsamaki; Angeliki G Tsaroucha; Maria G Sotiropoulou; Nikolaos D Ptohis; Aikaterini J Stipsanelli; Konstantinos E Dimitrakakis; Spyridon G Marinopoulos; Spyridon T Tsiouris; Aris J Antsaklis Journal: J Med Case Rep Date: 2010-03-17
Authors: Jingfang Cheng; Shijing Qiu; Usha Raju; Sandra R Wolman; Maria J Worsham Journal: Breast Cancer Res Treat Date: 2007-10-05 Impact factor: 4.872
Authors: Thomas E Rohan; Abdissa Negassa; Rowan T Chlebowski; Norman L Lasser; Anne McTiernan; Robert S Schenken; Mindy Ginsberg; Sylvia Wassertheil-Smoller; David L Page Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-08-25 Impact factor: 4.254
Authors: Chelsea Catsburg; Marc J Gunter; Lesley Tinker; Rowan T Chlebowski; Michael Pollak; Howard D Strickler; Michele L Cote; David L Page; Thomas E Rohan Journal: J Cancer Epidemiol Date: 2015-05-28